[1]
“Expression Profiling of Claudin 18.2 in Resected Specimens and Endoscopic Biopsies from Patients with Gastric and Gastroesophageal Junction Adenocarcinoma: A Review”, AGDD, vol. 7, no. 1, pp. 6–11, Sep. 2024, doi: 10.5281/zenodo.22179505.